OneMain vs. Upstart: Which Consumer Loan Stock Is a Better Buy in 2026?

OneMain generated nearly $6.2B of FY2025 revenue and $783M of net income, while Upstart posted about $1.1B of revenue, returned to profitability at $53.6M net income, and is expected to grow revenue nearly 36% in 2026 to more than $1.4B. The article favors Upstart on faster growth and a slightly higher-quality borrower base, despite OneMain’s cheaper valuation at 7.8x forward P/E versus Upstart’s 35.1x. Key risks remain credit quality, customer concentration, and regulatory scrutiny around AI lending.

Analysis

The market is underpricing the spread between “credit beta” and “model beta.” OMF is the cleaner near-term earnings story only if delinquencies stabilize, but that path is inherently lagged: nonprime charge-offs typically inflect after the macro starts weakening, not when the consumer headlines turn. UPST, by contrast, has the more convex setup because every additional partner, product, or approval-rate improvement scales with limited balance-sheet drag; the catch is that the business is still one adverse model-cycle away from a sharp multiple reset.

The second-order winner is JPM-style balance sheet lenders and other low-cost-funding incumbents, not because they have the best growth, but because tighter credit spreads and more selective underwriting can let them cherry-pick prime borrowers while fintechs absorb execution risk. SOFI is the more important competitive pressure on UPST than the article implies: if SOFI keeps tightening its product stack and distribution, it can siphon higher-quality borrowers and partners, forcing UPST to spend more on incentives just to hold volume. That would compress take rates before it shows up in reported revenue.

For OMF, the key catalyst is not revenue growth; it is whether the delinquency uptick proves transitory over the next 1-2 quarters. If credit trends stabilize, the stock can rerate modestly because valuation already implies a stressed book; if not, downside can accelerate quickly as buyback capacity and FCF assumptions get revised. For UPST, the main risk is a hidden concentration unwind: if one or two major funding partners change allocation terms, revenue could slow faster than consensus expects even if demand remains healthy.

The contrarian angle is that the “AI winner” trade may already be partially crowded, while the market may be too dismissive of OMF’s optionality from any benign macro surprise. If the consumer proves resilient into year-end, OMF’s low multiple gives more room for mean reversion than UPST’s premium multiple gives for disappointment. The asymmetry favors owning the cheaper name only as a tactical trade, while treating UPST as the higher-beta momentum asset that must be protected with hard risk limits.

Key Decisions for Investors

• Long UPST / short OMF as a 3-6 month relative-value trade only if credit data stays stable; target 15-20% spread capture, stop if delinquency or partner-concentration headlines worsen.
• Buy OMF on weakness for a 1-2 quarter mean-reversion trade; upside is multiple expansion if delinquencies peak, but cut risk quickly if charge-offs keep rising.
• Avoid chasing UPST outright into strength; instead use call spreads 3-6 months out to express upside from partner expansion while limiting exposure to a model or funding shock.
• Pair SOFI long against UPST short if you believe higher-quality borrower acquisition will compress UPST’s economics; this is a 6-12 month structural relative-value expression.
• For more defensive exposure to consumer credit, rotate capital toward JPM over both OMF and UPST if your base case is a late-cycle slowdown; lower upside, but materially better downside protection.